PAWBIO Trademark

Trademark Overview


On Tuesday, September 10, 2024, a trademark application was filed for PAWBIO with the United States Patent and Trademark Office. The USPTO has given the PAWBIO trademark a serial number of 98743208. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 8, 2025. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The PAWBIO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

processing and treating of chemical reagents, namely, the custom manufacture of chemical reagents; custom manufacturing of Antibody drugs; processing of biomedical preparations, namely, the custom manufacture of biopharmaceutical preparations; processing of pharmaceutical preparations, namely, the custom manufacture of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals

consulting services in the field of technological product development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biological research; biomedical research services; veterinary research; biotechnology research
pawbio

General Information


Serial Number98743208
Word MarkPAWBIO
Filing DateTuesday, September 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and Servicesprocessing and treating of chemical reagents, namely, the custom manufacture of chemical reagents; custom manufacturing of Antibody drugs; processing of biomedical preparations, namely, the custom manufacture of biopharmaceutical preparations; processing of pharmaceutical preparations, namely, the custom manufacture of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals
Goods and Servicesconsulting services in the field of technological product development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biological research; biomedical research services; veterinary research; biotechnology research

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCOUNTY LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCOUNTY LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Tuesday, September 10, 2024NEW APPLICATION ENTERED
Tuesday, September 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 16, 2024NON-FINAL ACTION E-MAILED
Monday, December 16, 2024NON-FINAL ACTION WRITTEN
Monday, December 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 16, 2024ASSIGNED TO EXAMINER
Monday, March 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED